Revenue
2020
2021
2022
2023
2024
2025
Ipsen SA (IPN)
Price€164.70Cached quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | €3.93B | €3.57B | €3.31B | €3.16B | €3.00B | €2.69B |
| Gross profit | €3.18B | €2.96B | €2.74B | €2.63B | €2.56B | €2.20B |
| Gross margin | 80.89% | 82.69% | 82.72% | 83.28% | 85.38% | 81.74% |
| Research & development | €754.0M | €686.6M | €619.3M | €445.3M | €424.4M | €405.6M |
| Operating expenses | €2.23B | €2.46B | €1.92B | €1.90B | €1.74B | €1.67B |
| Operating income | €945.1M | €496.7M | €816.0M | €729.9M | €824.7M | €524.8M |
| Operating margin | 24.05% | 13.90% | 24.68% | 23.12% | 27.50% | 19.54% |
| EBITDA | €1.25B | €1.18B | €1.01B | €1.07B | — | — |
| EBITDA margin | 31.76% | 32.99% | 30.45% | 34.00% | — | — |
| Net income | €443.5M | €347.3M | €647.2M | €647.5M | €646.7M | €548.9M |
| Net profit margin | 11.29% | 9.72% | 19.57% | 20.51% | 21.56% | 20.43% |
| Basic EPSper basic share | €5.37 | €4.18 | €7.79 | €7.87 | €7.82 | €6.61 |
| Diluted EPSper diluted share | €5.32 | €4.15 | €7.73 | €7.81 | €7.76 | €6.57 |